ASX - By Stock
|
NSX |
Re:
Ann: Non-Renounceable Issue
|
|
Roadrunner1717
|
52 |
9.5K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
52
|
9.5K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Next Science reports FY23 Result
|
|
Roadrunner1717
|
15 |
4.7K |
1 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
15
|
4.7K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: XPERIENCE study findings published
|
|
Roadrunner1717
|
30 |
10K |
0 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Bell Potter fined in 2017 for price manipulation
|
|
Roadrunner1717
|
27 |
9.6K |
0 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
27
|
9.6K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: XPERIENCE study findings published
|
|
Roadrunner1717
|
30 |
10K |
0 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
30
|
10K
|
0
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Roadrunner1717
|
932 |
1.1M |
0 |
19/12/23 |
19/12/23 |
Charts
|
932
|
1.1M
|
0
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Roadrunner1717
|
932 |
1.1M |
1 |
19/12/23 |
19/12/23 |
Charts
|
932
|
1.1M
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Bell Potter fined in 2017 for price manipulation
|
|
Roadrunner1717
|
27 |
9.6K |
1 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
27
|
9.6K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 3Y - A Stockburger
|
|
Roadrunner1717
|
1 |
446 |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
1
|
446
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Trading Halt
|
|
Roadrunner1717
|
14 |
6.7K |
5 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
14
|
6.7K
|
5
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 3Z - Judith Mitchell
|
|
Roadrunner1717
|
8 |
4.4K |
3 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
8
|
4.4K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
5 |
1.7K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
5
|
1.7K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation - Q2 2023
|
|
Roadrunner1717
|
22 |
6.7K |
0 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
22
|
6.7K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 3Z - Judith Mitchell
|
|
Roadrunner1717
|
8 |
4.4K |
2 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
8
|
4.4K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation - Q2 2023
|
|
Roadrunner1717
|
22 |
6.7K |
1 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
22
|
6.7K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appointment of new Managing Director and CEO
|
|
Roadrunner1717
|
4 |
2.3K |
2 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
4
|
2.3K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Ceasing to be a substantial holder
|
|
Roadrunner1717
|
4 |
2.1K |
1 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 4C - 30 September 2022
|
|
Roadrunner1717
|
23 |
6.6K |
4 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
23
|
6.6K
|
4
|
|
ASX - By Stock
|
NXS |
Re:
Next Science Price Target Cut 44% to A$2.01/Share by Canaccord Genuity
|
|
Roadrunner1717
|
14 |
8.6K |
2 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
14
|
8.6K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Half Year Results Investor Presentation
|
|
Roadrunner1717
|
33 |
14K |
0 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
33
|
14K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Next Science to strengthen senior leadership presence in US
|
|
Roadrunner1717
|
2 |
1.2K |
5 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
2
|
1.2K
|
5
|
|
ASX - By Stock
|
NXS |
Re:
Ann: 2021 Annual Report
|
|
Roadrunner1717
|
17 |
8.0K |
2 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
17
|
8.0K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
16 |
5.6K |
2 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
16
|
5.6K
|
2
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Roadrunner1717
|
932 |
1.1M |
3 |
02/02/22 |
02/02/22 |
Charts
|
932
|
1.1M
|
3
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Roadrunner1717
|
932 |
1.1M |
1 |
10/12/21 |
10/12/21 |
Charts
|
932
|
1.1M
|
1
|
|
ASX - By Stock
|
NXS Biotech |
Re:
Xperience in Orthopedics this week
|
|
Roadrunner1717
|
14 |
6.1K |
3 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
14
|
6.1K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
News: NXS Next Science Notes Change Of Interests By Founder Matthew Myntti
|
|
Roadrunner1717
|
9 |
3.6K |
1 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
9
|
3.6K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
News: NXS Next Science Notes Change Of Interests By Founder Matthew Myntti
|
|
Roadrunner1717
|
9 |
3.6K |
1 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
9
|
3.6K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Change in substantial holding
|
|
Roadrunner1717
|
3 |
1.4K |
1 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 4C - 30 June 2021
|
|
Roadrunner1717
|
5 |
2.1K |
2 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
5
|
2.1K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Update on expected revenue for H1
|
|
Roadrunner1717
|
70 |
22K |
1 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
70
|
22K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
27 |
9.1K |
0 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
27
|
9.1K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: XPerience No Rinse Antimicrobial Solution cleared by FDA
|
|
Roadrunner1717
|
44 |
14K |
1 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
44
|
14K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
27 |
9.7K |
2 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
27
|
9.7K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Non-renewal of 3M distribution agreement
|
|
Roadrunner1717
|
42 |
13K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
42
|
13K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Non-renewal of 3M distribution agreement
|
|
Roadrunner1717
|
42 |
13K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
42
|
13K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Non-renewal of 3M distribution agreement
|
|
Roadrunner1717
|
42 |
13K |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
42
|
13K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Non-renewal of 3M distribution agreement
|
|
Roadrunner1717
|
42 |
13K |
0 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
42
|
13K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Non-renewal of 3M distribution agreement
|
|
Roadrunner1717
|
42 |
13K |
2 |
24/01/21 |
24/01/21 |
ASX - By Stock
|
42
|
13K
|
2
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Roadrunner1717
|
932 |
1.1M |
1 |
09/12/20 |
09/12/20 |
Charts
|
932
|
1.1M
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Managing Director's EGM Address
|
|
Roadrunner1717
|
8 |
2.8K |
3 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
8
|
2.8K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 Sept 2020
|
|
Roadrunner1717
|
10 |
3.5K |
2 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
10
|
3.5K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Successful completion of Share Purchase Plan
|
|
Roadrunner1717
|
4 |
1.9K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
4
|
1.9K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
SPP
|
|
Roadrunner1717
|
1 |
453 |
3 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
1
|
453
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
34 |
11K |
2 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
34
|
11K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
34 |
11K |
3 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
34
|
11K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Roadrunner1717
|
34 |
11K |
3 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
34
|
11K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Quarterly Activities Report & Appendix 4C - 30 June 2020
|
|
Roadrunner1717
|
6 |
3.9K |
1 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
6
|
3.9K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: S&P DJI Announces June 2020 Quarterly Rebalance
|
|
Roadrunner1717
|
10 |
3.5K |
1 |
21/06/20 |
21/06/20 |
ASX - By Stock
|
10
|
3.5K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
News: NXS Next Science Sees Revenue To Be Constrained In Q2
|
|
Roadrunner1717
|
5 |
3.5K |
2 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
5
|
3.5K
|
2
|
|